• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[循环中抗苗勒管激素水平低而卵泡刺激素水平正常:在体外受精程序中的预后如何?]

[Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].

作者信息

Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S, Mayenga J-M, Kulski O, Cohen-Bacrie P, Benaim J-L, Belaisch-Allart J

机构信息

Service de gynécologie-obstétrique et médecine de la reproduction, centre hospitalier des 4-Villes, site de Sèvres, 141 Grande-Rue, Sèvres, France.

出版信息

Gynecol Obstet Fertil. 2012 Jul-Aug;40(7-8):411-8. doi: 10.1016/j.gyobfe.2012.02.001. Epub 2012 Apr 20.

DOI:10.1016/j.gyobfe.2012.02.001
PMID:22521986
Abstract

OBJECTIVE

To evaluate the results of controlled ovarian hyperstimulation (COH) for IVF in patients with low anti-Müllerian hormone (AMH) and normal basal follicle stimulating hormone (FSH) and Estradiol levels (≤50 pg/mL).

PATIENTS AND METHODS

A retrospective cohort study including 704 patients for whom AMH and FSH levels (measured between days 3 and 5 of the menstrual cycle) were available, is performed in the IVF center at the Sèvres Hospital (France). Three groups are designed and analyzed: group 1 with AMH less or equal to 2 ng/mL and FSH less or equal to 10 mUI/mL (study group), Group 2 with AMH greater than 2 ng/mL and FSH less or equal to 10 mUI/mL (control group) and Group 3 with AMH less or equal to 2 ng/mL and FSH greater than 10 mUI/mL (group with decreased ovarian reserve).

RESULTS

IVF outcome for patients from the study group is significantly worse than that of the second but not than that of the third group. In the first group, the number of retrieved oocytes, the number of total obtained embryos, the clinical pregnancy rate and the live birth rate are significantly lower than in the second group; moreover, there are more cancelled cycles because of poor response in the first group. There is no difference with the third group.

DISCUSSION AND CONCLUSIONS

This study shows that women with a low baseline AMH have a similar response to COH to the poor responders patients with a decreased ovarian reserve revealed by an elevated FSH level. Thus, when a woman undergoing IVF cycle presents a low AMH, she might be considered as a poor responder patient regardless of the FSH level and, although the clinical pregnancy rate is not so disappointing (18%), the couple should be informed of a higher risk of cycle cancellation.

摘要

目的

评估抗苗勒管激素(AMH)水平低、基础促卵泡生成素(FSH)和雌二醇水平正常(≤50 pg/mL)的患者接受体外受精(IVF)时控制性卵巢刺激(COH)的结果。

患者与方法

在法国瑟夫尔医院的IVF中心进行了一项回顾性队列研究,纳入了704例可获得AMH和FSH水平(在月经周期第3至5天测量)的患者。设计并分析了三组:第1组AMH小于或等于2 ng/mL且FSH小于或等于10 mUI/mL(研究组),第2组AMH大于2 ng/mL且FSH小于或等于10 mUI/mL(对照组),第3组AMH小于或等于2 ng/mL且FSH大于10 mUI/mL(卵巢储备功能下降组)。

结果

研究组患者的IVF结局明显比第二组差,但不比第三组差。在第一组中,回收的卵母细胞数量、获得的胚胎总数、临床妊娠率和活产率均明显低于第二组;此外,第一组因反应不良而取消的周期更多。与第三组无差异。

讨论与结论

本研究表明,基线AMH水平低的女性对COH的反应与FSH水平升高所显示的卵巢储备功能下降的反应不良患者相似。因此,当接受IVF周期的女性AMH水平低时,无论FSH水平如何,都可被视为反应不良患者,尽管临床妊娠率并非如此令人失望(18%),但应告知这对夫妇取消周期的风险更高。

相似文献

1
[Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].[循环中抗苗勒管激素水平低而卵泡刺激素水平正常:在体外受精程序中的预后如何?]
Gynecol Obstet Fertil. 2012 Jul-Aug;40(7-8):411-8. doi: 10.1016/j.gyobfe.2012.02.001. Epub 2012 Apr 20.
2
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.循环基础抗苗勒管激素水平作为接受体外受精卵巢刺激的女性卵巢反应的预测指标。
Fertil Steril. 2009 Nov;92(5):1586-93. doi: 10.1016/j.fertnstert.2008.08.127. Epub 2008 Oct 18.
3
Relevance of anti-Mullerian hormone measurement in a routine IVF program.抗苗勒管激素检测在常规体外受精程序中的相关性。
Hum Reprod. 2008 Jun;23(6):1359-65. doi: 10.1093/humrep/den108. Epub 2008 Apr 2.
4
Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.抗苗勒管激素:卵泡早期、排卵期及黄体中期水平与卵胞浆内单精子注射患者卵巢反应及周期结局的相关性
Fertil Steril. 2008 Jun;89(6):1670-6. doi: 10.1016/j.fertnstert.2007.05.040. Epub 2007 Jul 20.
5
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.血清抗苗勒管激素/苗勒管抑制物质似乎是比促卵泡激素、抑制素B或雌二醇更具鉴别性的辅助生殖技术结局标志物。
Fertil Steril. 2004 Nov;82(5):1323-9. doi: 10.1016/j.fertnstert.2004.03.061.
6
Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.利用卵巢储备参数预测接受体外受精的女性的活产率。
Eur J Obstet Gynecol Reprod Biol. 2013 Jun;168(2):173-7. doi: 10.1016/j.ejogrb.2013.01.013. Epub 2013 Feb 26.
7
The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.抗苗勒管激素在个体化激素剂量算法中的添加并未改善卵巢反应的预测-一项随机对照试验。
Hum Reprod. 2017 Apr 1;32(4):811-819. doi: 10.1093/humrep/dex012.
8
The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.抗苗勒管激素和窦卵泡计数预测卵母细胞和胚胎潜能。
Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2):166-70. doi: 10.1016/j.ejogrb.2010.02.029. Epub 2010 Mar 11.
9
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.在使用促性腺激素释放激素激动剂-促性腺激素治疗刺激的辅助生殖技术周期中,基础及刺激第5天抗苗勒管激素血清浓度作为卵巢反应和妊娠的预测指标。
Hum Reprod. 2005 Apr;20(4):915-22. doi: 10.1093/humrep/deh718. Epub 2005 Jan 21.
10
Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.抗苗勒管激素与窦卵泡计数用于定义 FSH 的起始剂量。
Reprod Biomed Online. 2013 Oct;27(4):390-9. doi: 10.1016/j.rbmo.2013.07.008. Epub 2013 Jul 23.

引用本文的文献

1
Anti-müllerian hormone as a predictor for live birth among women undergoing IVF/ICSI in different age groups: an update of systematic review and meta-analysis.抗苗勒氏管激素作为不同年龄组接受 IVF/ICSI 治疗的女性活产预测指标:系统评价和荟萃分析的更新。
Arch Gynecol Obstet. 2023 Jul;308(1):43-61. doi: 10.1007/s00404-022-06683-1. Epub 2022 Jul 30.
2
An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review.基于预测性遗传因素的卵巢刺激中卵巢反应的计算模型:系统评价。
J Assist Reprod Genet. 2021 Aug;38(8):2007-2020. doi: 10.1007/s10815-021-02141-0. Epub 2021 Mar 31.
3
Predictive parameters of arteriovenous fistula maturation in patients with end-stage renal disease.
终末期肾病患者动静脉内瘘成熟的预测参数
Kidney Res Clin Pract. 2018 Sep;37(3):277-286. doi: 10.23876/j.krcp.2018.37.3.277. Epub 2018 Sep 30.
4
Does loop electrosurgical excision procedure of the uterine cervix affect anti-Müllerian hormone levels?
Biomed Res Int. 2014;2014:875438. doi: 10.1155/2014/875438. Epub 2014 Feb 23.
5
Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction.辅助生殖中抗苗勒管激素与促卵泡生成素之间的差异
Obstet Gynecol Int. 2013;2013:383278. doi: 10.1155/2013/383278. Epub 2013 Dec 18.
6
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception.基于抗苗勒管激素的预测活产在辅助受孕中的外部验证。
J Ovarian Res. 2013 Jan 7;6(1):3. doi: 10.1186/1757-2215-6-3.